Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2020 Filed May 13, 2020 20:36 UTC |
Hurlburt ElizabethEVP, Head of Clinical Ops.
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 37,500 | $5.63 Strike: $5.63 | $211,125.00 |
DisclosureSEC source: 0001213900-20-012013 · doc4.xml · derivative · entry 2 Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| March 18, 2020 Filed Mar 18, 2020 20:25 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,500 | $2.61 | $9,135.00 |
DisclosureSEC source: 0001213900-20-006779 · doc4.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,075 Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 16:18 UTC |
Mounts PhoebeGeneral Counsel
|
PurchaseCommon Stock | 3,250 | $3.05 | $9,912.50 |
DisclosureSEC source: 0001213900-20-006882 · doc4.xml · nonDerivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,675 Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:47 UTC |
Mounts PhoebeGeneral Counsel
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 24,764 | $5.63 Strike: $5.63 | $139,421.32 |
DisclosureSEC source: 0001213900-20-004979 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,764 Underlying: Common Stock · 24,764 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:46 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 100,630 | $5.63 Strike: $5.63 | $566,546.90 |
DisclosureSEC source: 0001213900-20-004977 · doc4.xml · derivative · entry 2 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,630 Underlying: Common Stock · 100,630 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:46 UTC |
Kaplan MyronDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004978 · doc4.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:48 UTC |
Dillione JanetDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004981 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:48 UTC |
Lefkowitz Steven WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004982 · doc4.xml · derivative · entry 6 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F3 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:47 UTC |
Khan MehmoodDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004980 · doc4.xml · derivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:43 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 24,764 | $5.63 Strike: $5.63 | $139,421.32 |
DisclosureSEC source: 0001213900-20-004975 · doc4.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,764 Underlying: Common Stock · 24,764 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:42 UTC |
Hurlburt ElizabethEVP, Head of Clinical Ops.
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 24,764 | $5.63 Strike: $5.63 | $139,421.32 |
DisclosureSEC source: 0001213900-20-004974 · doc4.xml · derivative · entry 2 Masson Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,764 Underlying: Common Stock · 24,764 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:32 UTC |
DUNTON ALAN WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004972 · doc4.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F2 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 16:18 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 1,706 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-004256 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 Underlying: Common Stock · 1,706 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 17:05 UTC Amendment |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 1,706 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-004441 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 Underlying: Common Stock · 1,706 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| January 07, 2020 Filed Feb 28, 2020 02:48 UTC |
Lefkowitz Steven WDirector
|
OtherWarrant (Right to Purchase Common Stock) · Derivative | 3,000 | $4.50 Strike: $4.50 | $13,500.00 |
DisclosureSEC source: 0001213900-20-004982 · doc4.xml · derivative · entry 5 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Wade Capital Corp Money Purchase Plan Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2020-01-08 Read SEC document |
| January 07, 2020 Filed Feb 28, 2020 02:48 UTC |
Lefkowitz Steven WDirector
|
OtherWarrant (Right to Purchase Common Stock) · Derivative | 4,500 | $4.50 Strike: $4.50 | $20,250.00 |
DisclosureSEC source: 0001213900-20-004982 · doc4.xml · derivative · entry 4 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires 2020-01-08 Read SEC document |
| January 07, 2020 Filed Feb 28, 2020 02:48 UTC |
Lefkowitz Steven WDirector
|
OtherCommon Stock | 3,000 | $4.50 | $13,500.00 |
DisclosureSEC source: 0001213900-20-004982 · doc4.xml · nonDerivative · entry 2 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Wade Capital Corp Money Purchase Plan Disclosed balance after: 30,152 F2 · ownership.direct: The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control). Read SEC document |
| January 07, 2020 Filed Feb 28, 2020 02:48 UTC |
Lefkowitz Steven WDirector
|
OtherCommon Stock | 4,500 | $4.50 | $20,250.00 |
DisclosureSEC source: 0001213900-20-004982 · doc4.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,776 F1 · ownership.direct: Includes 24,963 shares held by the reporting person for the benefit of his minor son. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 17:24 UTC |
Mounts PhoebeGeneral Counsel
|
PurchaseCommon Stock | 1,425 | $7.04 | $10,037.56 |
DisclosureSEC source: 0001213900-20-000069 · doc4.xml · nonDerivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,425 Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:09 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 17,000 | $6.58 | $111,924.60 |
DisclosureSEC source: 0001213900-19-026361 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,017 F1 · price: Reflects the weighted average price of purchases made on the NYSE American on December 13, 2019. The shares were purchased in multiple transactions at prices ranging from $6.47 to $6.75, inclusive. The reporting person undertakes to provide to CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 17:21 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 2,099 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-023937 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,099 Underlying: Common Stock · 2,099 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 17:14 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 5,000 | $6.81 | $34,050.00 |
DisclosureSEC source: 0001213900-19-019413 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,734 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $6.74 to a high of $6.85 per share. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:13 UTC |
Cook Robert W.Chief Financial Officer
|
PurchaseCommon Stock | 1,000 | $6.88 | $6,879.30 |
DisclosureSEC source: 0001213900-19-019412 · doc4.xml · nonDerivative · entry 1 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,517 Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 21:19 UTC |
Lefkowitz Steven WDirector
|
PurchaseCommon Stock | 5,000 | $6.75 | $33,750.00 |
DisclosureSEC source: 0001213900-19-019419 · doc4.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,276 F1 · ownership.direct: Includes 24,963 shares held by the reporting person for the benefit of his minor son. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 20:08 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 120,000 | $0.00 Strike: $6.82 | $0.00 |
DisclosureSEC source: 0001213900-19-019299 · ownership.xml · derivative · entry 2 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2029-09-26 F1 · derivative.exercise_date: The options will vest over four (4) years in four (4) equal annual installments on the first four (4) anniversaries of September 26, 2019, provided, in all cases, that Executive remains an employee of, or a consultant to, the Company through the applicable vesting date. Read SEC document |
| August 16, 2019 Filed Aug 16, 2019 16:08 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 6,000 | $8.06 | $48,360.00 |
DisclosureSEC source: 0001213900-19-016170 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,734 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $8.04 to a high of $8.07 per share. Read SEC document |
| August 16, 2019 Filed Aug 16, 2019 16:07 UTC |
Dillione JanetDirector
|
PurchaseCommon Stock | 6,147 | $8.19 | $50,343.93 |
DisclosureSEC source: 0001213900-19-016167 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,473 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $8.179 to a high of $8.199 per share. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:10 UTC |
Cook Robert W.Chief Financial Officer
|
PurchaseCommon Stock | 1,000 | $8.18 | $8,180.00 |
DisclosureSEC source: 0001213900-19-016280 · doc4.xml · nonDerivative · entry 1 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,517 Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:09 UTC |
Cook Robert W.Chief Financial Officer
|
PurchaseCommon Stock | 1,000 | $8.18 | $8,180.00 |
DisclosureSEC source: 0001213900-19-016279 · doc4.xml · nonDerivative · entry 1 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,517 Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 16:07 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 945 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-016167 · ownership.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 945 Underlying: Common Stock · 945 shares Expires not disclosed F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:06 UTC |
DUNTON ALAN WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 7,500 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001654954-19-008296 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-07-12 F2 · derivative.exercise_date: These options were granted on 7/12/2019. The options vest monthly with 100% vesting on the one-year anniversary of the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:06 UTC |
DUNTON ALAN WDirector
|
GrantRestricted Stock Units | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-008296 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 F1 · price: These Restricted Stock Units were granted on 7/12/2019. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest monthly with 100% vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| May 15, 2019 Filed May 17, 2019 09:24 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 1,126 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-006225 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226 Underlying: Common Stock · 226 shares Expires not disclosed F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2019 Filed May 17, 2019 09:24 UTC |
Dillione JanetDirector
|
PurchaseCommon Stock | 11,144 | $6.74 | $75,110.56 |
DisclosureSEC source: 0001654954-19-006225 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,326 F1 · price: Represents the weighted average purchase price of the shares purchased from a low of $6.72 to a high of $6.74 per share. F8 · balance_after: The issuer effected a 1-for-5 reverse stock split on March 26, 2019. All share and per share amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| May 01, 2019 Filed May 24, 2019 16:15 UTC |
Mounts PhoebeGeneral Counsel
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 70,000 | $0.00 Strike: $7.92 | $0.00 |
DisclosureSEC source: 0001654954-19-006551 · section16.xml · derivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-05-01 F1 · derivative.exercise_date: The options vest as follows: 42,000 vest equally over four years and 28,000 vest upon the achievement of designated milestones. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 20:49 UTC |
Cook Robert W.Chief Financial Officer
|
PurchaseCommon Stock | 100 | $9.35 | $935.00 |
DisclosureSEC source: 0001654954-19-003866 · section16.xml · nonDerivative · entry 1 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,517 F1 · balance_after: The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 20:15 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,500 | $7.55 | $18,875.00 |
DisclosureSEC source: 0001654954-19-003467 · section16.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,575 F1 · balance_after: The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 20:12 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
PurchaseCommon Stock | 5,000 | $7.73 | $38,650.00 |
DisclosureSEC source: 0001654954-19-003466 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,378 F1 · balance_after: The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 20:09 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
PurchaseCommon Stock | 15,000 | $1.69 | $25,350.00 |
DisclosureSEC source: 0001654954-19-003244 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,890 Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 16:06 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 20,000 | $1.65 | $33,000.00 |
DisclosureSEC source: 0001654954-19-003085 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,666 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 16:21 UTC |
Dillione JanetDirector
|
PurchaseCommon Stock | 42,000 | $1.67 | $69,972.00 |
DisclosureSEC source: 0001654954-19-002991 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,909 F1 · price: Represents the weighted average purchase price of the shares purchased from a low of $1.655 to a high of $1.670 per share. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:06 UTC |
DUNTON ALAN WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 100,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001654954-19-002247 · section16.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: These options were granted on 3/1/2019. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| March 01, 2019 Filed May 9, 2019 20:07 UTC Amendment |
DUNTON ALAN WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $8.50 | $0.00 |
DisclosureSEC source: 0001654954-19-005559 · section16.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: The vesting of the options was incorrectly reported in the original filing. F2 · derivative.exercise_date: These options were granted on 3/1/2019. The options vest one-third on the date of grant, one-third on the first anniversary of the date of grant and one-third on the second anniversary of the date of grant. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 16:02 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 4,213 | $1.78 Strike: $0.00 | $7,499.14 |
DisclosureSEC source: 0001654954-19-001754 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,213 Underlying: Common Stock · 4,213 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:22 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 400,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001654954-19-000386 · section16.xml · derivative · entry 2 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-01-10 F1 · derivative.exercise_date: These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC |
Kaplan MyronDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · derivative · entry 5 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-01-10 F2 · derivative.exercise_date: These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 4 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 3 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:15 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000381 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,666 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.